NRX Pharmaceuticals, Inc. SEC filings NRXP
NRX Pharmaceuticals, Inc. has 477 filings in SEC EDGAR's recent list, going back to Oct 13, 2017. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 18, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q/A | Amended quarterly report | Aug 12, 2022 | Sep 30, 2021 |
| 10-Q/A | Amended quarterly report | Aug 12, 2022 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 21, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 8, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 8, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 15, 2018 | Mar 31, 2018 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NRXP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1719406
- Former names
- Big Rock Partners Acquisition Corp. (until May 24, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.